Morningside Venture Investments Ltd (CIK 0001543112)

Latest company ownership

Shares held
12,806,342
Last filed at
Nov 18, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4
Shares held
4,997,302
Last filed at
Aug 17, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
Shares held
1,947,993
Last filed at
Aug 17, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 29, 2023 Mar 31, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 37.5 -29,048 -0.41% ✗ $884.5K
Mar 27, 2023 Mar 29, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 17.5 -160,964 -2.24% ✗ $4.9M
Mar 21, 2023 Mar 23, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 27.5 -63,448 -0.88% ✗ $2M
Mar 16, 2023 Mar 17, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 45.0 -9,122 -0.13% ✗ $296.9K
Mar 14, 2023 Mar 16, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 16.3 -220,714 -2.95% ✗ $7.4M
Mar 2, 2023 Mar 6, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 27.5 -50,000 -0.66% ✗ $1.7M
Feb 22, 2023 Feb 28, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 27.5 -50,000 -0.66% ✗ $1.7M
Feb 22, 2023 Feb 24, 2023 Amylyx Pharmaceuticals, Inc. 10% Owner Sell 17.5 -100,000 -1.30% ✗ $3.6M
Feb 3, 2023 Feb 7, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 20.0 -65,000 -1.18% ✗ $454K
Feb 1, 2023 Feb 3, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 20.0 -90,000 -1.61% ✗ $637.5K
Jan 30, 2023 Feb 1, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 20.0 -60,000 -1.06% ✗ $419.7K
Jan 25, 2023 Jan 27, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 30.0 -50,000 -0.88% ✗ $342.5K
Jan 23, 2023 Jan 25, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 17.5 -160,000 -2.72% ✗ $1.1M
Jan 17, 2023 Jan 19, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 51.3 -6,114 -0.10% ✗ $41.5K
Jan 12, 2023 Jan 17, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 51.3 -6,971 -0.12% ✗ $47.9K
Jan 5, 2023 Jan 9, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 40.0 -15,162 -0.26% ✗ $105.4K
Dec 29, 2022 Jan 5, 2023 Kezar Life Sciences, Inc. 10% Owner Sell 30.0 -55,500 -0.93% ✗ $396.2K
Oct 3, 2022 Oct 5, 2022 Kezar Life Sciences, Inc. 10% Owner Sell 30.0 -32,312 -0.53% ✗ $283.8K
Jan 11, 2022 Mar 17, 2022 Amylyx Pharmaceuticals, Inc. 10% Owner Buy 93.8 +263,158 2.53% ✗ $5M
Jan 11, 2022 Jan 25, 2022 Amylyx Pharmaceuticals, Inc. 10% Owner Buy 93.8 +263,158 2.53% ✗ $5M
Nov 18, 2021 Nov 18, 2021 Apellis Pharmaceuticals, Inc. 10% Owner Buy 90.0 +250,000 1.99% ✗ $10M
Feb 4, 2020 Feb 6, 2020 Kezar Life Sciences, Inc. 10% Owner Buy 100.0 +3,800,000 164.57% ✗ $9.9M
Jan 13, 2020 Jan 21, 2020 Apellis Pharmaceuticals, Inc. 10% Owner Buy 95.0 +540,540 4.50% ✗ $20M
Mar 11, 2019 Mar 13, 2019 Apellis Pharmaceuticals, Inc. 10% Owner Buy 93.8 +441,176 3.81% ✗ $7.5M
Sep 20, 2018 Sep 24, 2018 Apellis Pharmaceuticals, Inc. 10% Owner Buy 77.5 +81,323 0.71% ✗ $1.6M
Sep 17, 2018 Sep 19, 2018 Apellis Pharmaceuticals, Inc. 10% Owner Buy 87.5 +140,000 1.23% ✗ $2.6M
Jun 25, 2018 Jun 27, 2018 Kezar Life Sciences, Inc. 10% Owner Buy 100.0 +250,000 12.14% ✗ $3.8M